Advertisement


Charles L. Loprinzi, MD, on Olanzapine for Prevention of CINV

2015 Palliative Care in Oncology Symposium

Advertisement

Charles L. Loprinzi, MD, of the Mayo Clinic, discusses olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy (Abstract 176).



Related Videos

Palliative Care

Judith Vick, MD Candidate, and Rachelle E. Bernacki, MD, on A New Clinical Tool: The “Surprise Question”

Judith Vick, MD Candidate, of Johns Hopkins University School of Medicine, and Rachelle E. Bernacki, MD, of Dana-Farber Cancer Institute, discuss a tool that could help clinicians identify seriously ill patients who would benefit from conversations about their goals and values (Abstract 8).

Palliative Care

Kathleen Foley, MD, on Palliative Care in Low-Resource Settings

Kathleen Foley, MD, of Memorial Sloan Kettering Cancer Center, discusses the challenges of integrating palliative care in areas without sufficient resources or health-care infrastructure.

Palliative Care
Symptom Management
Lung Cancer

Amelie Harle, MD, on Aprepitant for Cough in Lung Cancer

Amelie Harle, MD, of the Christie NHS Foundation Trust, discusses a clinical trial––the first of its kind—designed to assess the efficacy of an antitussive in patients with lung cancer (Abstract 2).

Palliative Care

Vicki Jackson, MD, MPH, on Effective Care Integration and the Comanagement Model

Vicki Jackson, MD, MPH, of Massachusetts General Hospital, summarizes her keynote lecture (plenary talk).

Palliative Care

Jennifer S. Temel, MD's Expert Perspective: Palliative Care in 2015

As Steering Committee Chair of this year’s symposium, Jennifer S. Temel, MD, of Massachusetts General Hospital, discusses the goals and highlights of the meeting.

Advertisement

Advertisement




Advertisement